Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   
Aspen Pharmacare Holdings Ltd.  –  A2X:APNJ  
     
Prices at least 15 minutes delayed. Source: A2X
 
Watch APNJ 
 
 
Zoom: 
1D 2D 3M 1Y 3Y 5Y 10Y
JSE Overall 112 418 0.57%
 
More performance data
10 Day Trading Range
126.82 12,813.50
Peer Comparison
ASPEN (APN)128.00 (0.05%)
NUMERAL (XII)0.40 (2.56%)
Customise
Analysts' positions on APNJ
Detailed forecasts
Visual Calendar for APN
APN Calendar Table
Sector: Pharmaceuticals and Biotechnology
 
APNJ  Latest Market Data
Friday's Close130.67   P/E Ratio64.18
Today's Open127.94   EPS - TTM 203.60
Best Bid127.96 x 315   DPS - TTM Dividend (cps) 211 211
Best Offer128.19 x 635   Dividend Yield 1.61
Volume 57 906   Market Cap 57.13bn
Day's Range126.91–128.14   Shares In Issue 446.25m
Detailed quote
Exchange News Latest News
Latest Results
6 months ended Dec 2025 (published Mar 2026) Interim
(ZAR million)%chgDec 25 Dec 24R
Turnover-4.3% 17 078.0 17 849.0
Attributable Income-38.4% 1 472.0 2 388.0
Market Cap (ZARm)-28.8% 52 117.5 73 209.9
EPS (ZARc)-38.4% 331.10 537.70
HEPS (Cont Ops)(ZARc)-45.9% 233.20 431.20
DPS (ZARc)---
View Comment Detailed financials
 
Nature of Business
Aspen is a global specialty and branded pharmaceutical company, improving the health of patients across the world through its high quality and affordable medicines. Active at every stage of the value chain, the Group is uniquely diversified by geography, product, and manufacturing capability.
 
Portfolio  
Watch List  
Recently viewed


 
 
* Price data source: A2X. All other statistics calculated by ProfileData.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData


Follow us on: